The investment will accelerate the company’s commercial rollout of functional yeast proteins designed to replace eggs and additives in mainstream food categories
The funding, including an $8m Series A, will be used to grow its clinically validated gut–x axis product portfolio, scale retail and ecommerce distribution and strengthen its...
Get breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry.